| Autor: |
Sun Koo Yoo, Syed Faizan Mehdi, Suma Pusapati, Nimisha Mathur, Manasa Anipindi, Bruno Lunenfeld, Barbara Lowell, Huan Yang, Christine Noel Metz, Sawleha Arshi Khan, Derek Leroith, Jesse Roth |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Frontiers in Immunology, Vol 12 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
1664-3224 |
| DOI: |
10.3389/fimmu.2021.714177 |
| Popis: |
Sepsis continues to be a major cause of morbidity, mortality, and post-recovery disability in patients with a wide range of non-infectious and infectious inflammatory disorders, including COVID-19. The clinical onset of sepsis is often marked by the explosive release into the extracellular fluids of a multiplicity of host-derived cytokines and other pro-inflammatory hormone-like messengers from endogenous sources (“cytokine storm”). In patients with sepsis, therapies to counter the pro-inflammatory torrent, even when administered early, typically fall short. The major focus of our proposed essay is to promote pre-clinical studies with hCG (human chorionic gonadotropin) as a potential anti-inflammatory therapy for sepsis. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
